Stocktoria
Monte Rosa Therapeutics, Inc. GLUE
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-06-24
Monte Rosa Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| AQR CAPITAL MANAGEMENT LLC | 520,648 | $12.6M | 0.63% |
| BlackRock Finance, Inc. | 2,360,093 | $8.8M | 2.84% |
| CITADEL ADVISORS LLC | 172,371 | $4.2M | 0.21% |
| D. E. Shaw & Co., Inc. | 172,053 | $4.2M | 0.21% |
| TWO SIGMA INVESTMENTS, LP | 140,923 | $3.4M | 0.17% |
| RENAISSANCE TECHNOLOGIES LLC | 102,500 | $2.5M | 0.12% |
| Duquesne Family Office LLC | 297,600 | $7,202 | 0.36% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.